Irish economy set for robust growth, but risks remain – The Irish Times
Ireland’s economy is expected to be among the top five performers in Europe next year, continuing momentum from…
Eli Lilly-backed Insilico eyes beyond pharma with new AI models
Interview Biotech company shares jumped 46% in $300m Hong Kong debut Biotech firm Insilico Medicine leverages artificial intelligence…
China’s new commercial insurance model could broaden access to Alzheimer’s drugs
ChiÂna’s new comÂmerÂcial inÂsurÂance forÂmuÂlaÂry looks to exÂpand paÂtient acÂcess to Alzheimer’s disÂease medÂiÂcines from Eli LilÂly and…
UK lowers new medicine rebate scheme to 14.5% for 2026 – Endpoints News
UK lowers new medicine rebate scheme to 14.5% for 2026 Endpoints NewsIn win for pharma, UK cuts medicine rebate…
Why Ireland is struggling to fund the new weight-loss drugs
When the WHO issued new guidelines on drugs such as Ozempic and Mounjaro this week, it was widely…
Ireland dodged a bullet this year. But there’s a caveat – The Irish Times
The Irish economy dodged a bullet this year. Several of them, in fact. Back in April, we were…
Top 10 Healthcare Industry Predictions For 2026
The year 2026 will be a year of tumult in American healthcare. Getty Images As December kicks off,…
Trump admin claims win as UK bows to pressure on NHS drug spending – POLITICO
The NICE threshold will rise to £25,000 to £35,000 for every quality adjusted life year. In return for…
Ozempic-style drugs should be available to all, not just the rich, says WHO – POLITICO
The WHO wants pharma companies to consider tiered pricing (lower prices in lower-income countries) and voluntary licensing of…
Updated: CMS unveils negotiated prices for Ozempic, Wegovy and other drugs from second round of IRA talks – Endpoints News
Updated: CMS unveils negotiated prices for Ozempic, Wegovy and other drugs from second round of IRA talks Endpoints NewsU.S.…
How weight-loss drug Mounjaro is making Ireland the world’s fastest-growing economy – The Irish Times
Pharma giant Eli Lilly manufactures the ingredients for its weight-loss drug Mounjaro and its diabetes drug Zepbound in…
Are we all living inside an AI bubble? Inside circular deals and the quiet financial loop they created
Three years ago, generative AI was barely on anyone’s radar. Three months ago, circular deals were whispered about…